Year archive

Appili Therapeutics Inc. — 2025 filings

All 19 regulatory filings released by Appili Therapeutics Inc. (APLI) in 2025, sourced directly from the official regulator.

19 Filings

2025 Period

2025 filings (19)

Filing	Released	Lang
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2025-12-29	English
Material change report - English.pdf Capital/Financing Update	2025-12-29	English
News release - English.pdf Capital/Financing Update	2025-12-18	English
News release - English.pdf Share Issue/Capital Change	2025-11-05	English
News release - English.pdf Regulatory Filings	2025-09-09	English
News release - English.pdf Regulatory Filings	2025-08-06	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-06-26	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-06-26	English
Annual information form - English.pdf Governance Information FY 2025	2025-06-26	English
Annual MD&A - English.pdf Management Reports	2025-06-26	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-06-26	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-06-26	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2025	2025-06-26	English
News release - English.pdf Earnings Release FY 2025	2025-06-26	English
Material change report - English.pdf Regulatory Filings	2025-05-31	English
News release - English.pdf M&A Activity	2025-05-19	English
News release - English.pdf Regulatory Filings	2025-05-01	English
News release - English.pdf Regulatory Filings	2025-04-02	English
News release - English.pdf M&A Activity	2025-03-18	English